NVIDIA and Eli Lilly Announce $1 Billion AI Drug Discovery Co-Innovation Lab
Published 2026-01-12Ingested 2026-01-13Enterprise AI DeliveryMedium
Summary
On January 12, 2026, at the J.P. Morgan Healthcare Conference, NVIDIA and Eli Lilly announced a first-of-its-kind AI co-innovation lab with up to $1 billion in combined investment over five years in talent, infrastructure, and compute. The lab, based in the San Francisco Bay Area, will co-locate Lilly domain experts in biology, science, and medicine alongside NVIDIA AI model builders and engineers to develop AI models that accelerate drug discovery and development. The lab's infrastructure will
Alignment: Neutral
nvidiaeli-lillydrug-discoveryhealthcare-aienterprise-aibionemovera-rubinphysical-aijp-morgan-conference